Molecular design of the Cαβ interface favors specific pairing of introduced TCRαβ in human T cells

Journal of Immunology

Volumn 180, Issue 1, 2008, Pages 391-401

  Voss, Ralf Holger ^a   Willemsen, Ralph A ^b   Kuball, Jürgen ^c   Grabowski, Margarete ^a   Engel, Renate ^d   Intan, Ratna S ^a   Guillaume, Philippe ^e   Romero, Pedro ^f   Huber, Christoph ^a   Theobald, Matthias ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d European Institute for Research and Development of Transplantation Strategies   (Germany)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^f Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HETERODIMER; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; COMPUTER INTERFACE; CRYSTAL STRUCTURE; ELECTRICITY; HUMAN; HUMAN CELL; HYBRID; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; ANIMAL; CELL MEMBRANE; CHEMISTRY; DIMERIZATION; GENE TRANSFER; GENETICS; IMMUNOLOGY; METABOLISM; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN TRANSPORT; X RAY CRYSTALLOGRAPHY;

ANIMALS; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; GENE TRANSFER TECHNIQUES; HUMANS; MICE; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 40449129554     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.1.391     Document Type: Article

References (44)

1. Morgan, R. A., M. E. Dudley, J. R. Wunderlich, M. S. Hughes, J. C. Yang, R. M. Sherry, R. E. Royal, S. L. Topalian, U. S. Kammula, N. P. Restifo, et al. 2006. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
2. Theobald, M., J. Biggs, J. Hernandez, J. Lustgarten, C. Labadie, and L. A. Sherman. 1997. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J. Exp. Med. 185: 833-841.
3. Stanislawski, T., R. H. Voss, C. Lotz, E. Sadovnikova, R. A. Willemsen, J. Kuball, T. Ruppert, R. L. Bolhuis, C. J. Melief, C. Huber, et al. 2001. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol. 2: 962-970.
4. + T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 22: 117-129.
5. Li, Y., R. Moysey, P. E. Molloy, A. L. Vuidepot, T. Mahon, E. Baston, S. Dunn, N. Liddy, J. Jacob, B. K. Jakobsen, and J. M. Boulter. 2005. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat. Biotechnol. 23: 349-354.
6. Holler, P. D., P. O. Holman, E. V. Shusta, S. O'Herrin, K. D. Wittrup, and D. M. Kranz. 2000. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl. Acad. Sci. USA 97: 5387-5392.
7. Kessels, H. W., M. D. van den Boom, H. Spits, E. Hooijberg, and T. N. Schumacher. 2000. Changing T cell specificity by retroviral T cell receptor display. Proc. Natl. Acad. Sci. USA 97: 14578-14583.
8. Kessels, H. W., M. C. Wolkers, M. D. van den Boom, M. A. van der Valk, and T. N. Schumacher. 2001. Immunotherapy through TCR gene transfer. Nat. Immunol. 2: 957-961.
9. Schumacher, T. N. 2002. T-cell-receptor gene therapy. Nat. Rev. Immunol. 2: 512-519.
10. Naylor, K., G. Li, A. N. Vallejo, W. W. Lee, K. Koetz, E. Bryl, J. Witkowski, J. Fulbright, C. M. Weyand, and J. J. Goronzy. 2005. The influence of age on T cell generation and TCR diversity. J. Immunol. 174: 7446-7452.
11. Roszkowski, J. J., D. C. Yu, M. P. Rubinstein, M. D. McKee, D. J. Cole, and M. I. Nishimura. 2003. CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J. Immunol. 170: 2582-2589.
12. Zhang, T., X. He, T. C. Tsang, and D. T. Harris. 2004. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther. 11: 487-496.
13. Willemsen, R. A., M. E. Weijtens, C. Ronteltap, Z. Eshhar, J. W. Gratama, P. Chames, and R. L. Bolhuis. 2000. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther. 7: 1369-1377.
14. Kuball, J., M. L. Dossett, M. Wolfl, W. Y. Ho, R. H. Voss, C. Fowler, and P. D. Greenberg. 2007. Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood 109: 2331-2338.
15. Cohen, C. J., Y. F. Li, M. El-Gamil, P. F. Robbins, S. A. Rosenberg, and R. A. Morgan. 2007. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res. 67: 3898-3903.
16. Voss, R. H., J. Kuball, R. Engel, P. Guillaume, P. Romero, C. Huber, and M. Theobald. 2006. Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression. Immunol. Res. 34: 67-87.
17. Cohen, C. J., Y. Zhao, Z. Zheng, S. A. Rosenberg, and R. A. Morgan. 2006. Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res. 66: 8878-8886.
18. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274: 209-219.
19. Ding, Y. H., K. J. Smith, D. N. Garboczi, U. Utz, W. E. Biddison, and D. C. Wiley. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8: 403-411.
20. Lefranc, M. P. 2003. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 31: 307-310.
21. Lefranc, M. P., C. Pommié, Q. Kaas, E. Duprat, N. Bosc, D. Guiraudou, C. Jean, M. Ruiz, I. Da Piédade, M. Rouard, et al. 2005. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev. Comp. Immunol. 29: 185-203.
22. Schaft, N., R. A. Willemsen, J. de Vries, B. Lankiewicz, B. W. Essers, J. W. Gratama, C. G. Figdor, R. L. Bolhuis, R. Debets, and G. J. Adema. 2003. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR α β genes into primary human T lymphocytes. J. Immunol. 170: 2186-2194.
23. + T cells for melanoma immunotherapy in human MHC class I-transgenic mice. J. Immunol. 167: 5824-5831.
24. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne. 2000. The protein data bank. Nucleic Acids Res. 28: 235-242.
25. Guex, N., and M. C. Peitsch. 1997. Swiss-Model and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
26. Blank, U., B. Boitel, D. Mege, M. Ermonval, and O. Acuto. 1993. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma. Eur. J. Immunol. 23: 3057-3065.
27. Voss, R. H., J. Kuball, and M. Theobald. 2005. Designing TCR for cancer immunotherapy. Methods Mol. Med. 109: 229-256.
28. Grignani, F., T. Kinsella, A. Mencarelli, M. Valtieri, D. Riganelli, F. Grignani, L. Lanfrancone, C. Peschle, G. P. Nolan, and P. G. Pelicci. 1998. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58: 14-19.
29. Robert, B., P. Guillaume, I. Luescher, P. Romero, and J. P. Mach. 2000. Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes. Eur. J. Immunol. 30: 3165-3170.
30. Whelan, J. A., P. R. Dunbar, D. A. Price, M. A. Purbhoo, F. Lechner, G. S. Ogg, G. Griffiths, R. E. Phillips, V. Cerundolo, and A. K. Sewell. 1999. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163: 4342-4348.
31. Rosette, C., G. Werlen, M. A. Daniels, P. O. Holman, S. M. Alam, P. J. Travers, N. R. Gascoigne, E. Palmer, and S. C. Jameson. 2001. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15: 59-70.
32. Ridgway, J. B., L. G. Presta, and P. Carter. 1996. 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 9: 617-621.
33. Schreiber, G., and A. R. Fersht. 1996. Rapid, electrostatically assisted association of proteins. Nat. Struct. Biol. 3: 427-431.
34. Clackson, T., and J. A. Wells. 1995. A hot spot of binding energy in a hormone-receptor interface. Science 267: 383-386.
35. Irving, B. A., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64: 891-901.
36. McKee, M. D., T. M. Clay, S. A. Rosenberg, and M. I. Nishimura. 1999. Quantitation of T-cell receptor frequencies by competitive PCR: generation and evaluation of novel TCR subfamily and clone specific competitors. J. Immunother. 22: 93-102.
37. Savage, P. A., and M. M. Davis. 2001. A kinetic window constricts the T cell receptor repertoire in the thymus. Immunity 14: 243-252.
38. Kersh, G. J., E. N. Kersh, D. H. Fremont, and P. M. Allen. 1998. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9: 817-826.
39. Holmberg, K., S. Mariathasan, T. Ohteki, P. S. Ohashi, and N. R. Gascoigne. 2003. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR. J. Immunol. 171: 2427-2434.
40. Li, Z. G., W. P. Wu, and N. Manolios. 1996. Structural mutations in the constant region of the T-cell antigen receptor (TCR) β-chain and their effect on TCR α and β-chain interaction. Immunology 88: 524-530.
41. Sun, Z. Y., S. T. Kim, I. C. Kim, A. Fahmy, E. L. Reinherz, and G. Wagner. 2004. Solution structure of the CD3εδ ectodomain and comparison with CD3εγ as a basis for modeling T cell receptor topology and signaling. Proc. Natl. Acad. Sci. USA 101: 16867-16872.
42. Atwell, S., J. B. Ridgway, J. A. Wells, and P. Carter. 1997. Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J. Mol. Biol. 270: 26-35.
43. Chothia, C., D. R. Boswell, and A. M. Lesk. 1988. The outline structure of the T-cell α β receptor. EMBO J. 7: 3745-3755.
44. Labrecque, N., L. S. Whitfield, R. Obst, C. Waltzinger, C. Benoist, and D. Mathis. 2001. How much TCR does a T cell need? Immunity 15: 71-82.